查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1922976

磁浮心室輔助裝置市場按流量類型、裝置類型、治療用途、患者年齡層、最終用戶和分銷管道分類 - 全球預測（2026-2032 年）

MagLev Ventricular Assist Device Market by Flow Type, Device Type, Therapy Application, Patient Age Group, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年磁浮心室輔助裝置市值為 7.1528 億美元，預計到 2026 年將成長至 7.8752 億美元，預計到 2032 年將達到 14.8575 億美元，複合年成長率為 11.00%。

主要市場統計數據
基準年 2025 7.1528億美元
預計年份：2026年 7.8752億美元
預測年份：2032年 14.8575億美元
複合年成長率 (%) 11.00%

在臨床需求、技術進步、患者照護和設備創新等因素的共同推動下，重點在於推進磁浮心室輔助裝置（VAD）的實施。

磁浮心室輔助裝置（VAD）結合了先進的磁浮技術和新一代心血管支援技術，為醫療專業人員提供了減少血液相容性併發症和延長裝置使用壽命的途徑。早期採用該裝置的醫療中心強調，其無機械軸承設計以及由此帶來的剪切應力降低，能夠減少血液應變，從而減少溶血和血栓事件的發生。這些技術優勢引起了專注於持續循環支援的多學科團隊的廣泛關注。

技術創新、臨床實踐和醫療政策調整所帶來的變革性變化正在重塑磁浮心室輔助裝置的模式。

多項平行變革正在重新定義臨床醫生、製造商和醫療保健系統對持續機械循環支援（CMCS）的理解和應用。首先，磁浮平台技術的成熟使得體積更小、效率更高、且可程式設計的設備成為可能。這項發展促使人們重新評估患者選擇標準；如果設備在早期臨床應用中展現出良好的安全性和血流動力學穩定性，臨床醫生正在探索擴大其適應症的可能性。

分析2025年美國關稅對設備零件、供應鏈韌性和價值鏈策略採購決策的累積影響

2025年的關稅環境迫使植入式磁浮循環輔助系統重新檢視其零件籌資策略。如果關稅壁壘影響採購的零件，精密軸承、高性能磁鐵和電力電子裝置等關鍵子系統將面臨供應鏈成本上升的風險。因此，製造商和供應商正在加速供應商多元化，重點關注近岸外包和合格的替代供應商，以降低供應中斷風險並維持生產進度。

關鍵細分洞察，重點在於按設備架構、治療目的和使用者環境分類的不同臨床、商業和營運管道

血流特性的分析突顯了器械選擇和臨床應用的重要差異。具有連續流結構的器械，包括軸流和離心流器械，由於其緊湊的植入結構和持續的血流動力學管理，通常優先考慮長期循環支持。同時，脈動流器材在某些生理情況下仍然有用，因為節律性心臟支持可提供獨特的臨床益處。這些技術差異會影響手術方法、抗凝血策略和病患監測通訊協定。

以主要地區分析磁浮循環支援系統：闡明需求促進因素、臨床應用模式與政策環境

在美洲地區，先進的臨床基礎設施和集中式卓越中心支援新型循環支援平台的早期應用；學術醫院主導研究者主導的評估；大型醫療系統則優先考慮整合式診療路徑。這些趨勢推動著嚴格的數據收集，並影響支付方和醫療服務提供者尋求切實改善患者預後和資源利用的採購決策。從三級醫療機構向覆蓋廣泛的醫院網路過渡，需要考慮培訓、服務網路和遠端監測能力。

策略層面的公司洞察，塑造磁浮心室輔助裝置領域的競爭定位、創新重點與夥伴關係結構

領先的醫療器材開發商和專業Start-Ups憑藉其獨特的臨床證據生成能力、磁浮和電機控制領域的智慧財產權以及生產規模優勢脫穎而出。一些公司優先考慮快速推進臨床應用，透過與知名心臟中心合作、開展研究者主導的註冊研究和早期可行性研究來實現這一目標；而另一些公司則專注於建立穩健的供應鏈和可擴展的生產能力，以支持更廣泛的商業性推出。工程技術型公司與成熟的心血管器材製造商之間的合作，能夠在確保符合監管要求的同時，加速複雜子系統的臨床應用進程。

為產業領導者提供實用建議，以協調臨床證據、製造韌性和商業策略，從而成功部署磁浮

重點在於建立可靠的臨床證據管道，將前瞻性臨床試驗與全面的註冊登記相結合，以同時獲取對照試驗結果和真實世界表現指標。加強上市後監測，並在器材研發早期階段就與關鍵意見領袖（KOL）互動，將加速臨床認可，並為與支付者的討論提供必要數據。同時，投資供應商資格合格和區域製造夥伴關係，以降低貿易波動風險，並確保重症監護環境中器械的持續供應。

調查方法說明了用於產生此分析的嚴謹的一手和二手調查方法、專家參與以及跨部門檢驗。

本研究結合了對同儕審查的臨床文獻、監管申報文件和器械特定技術文件的系統性回顧，以及透過訪談心臟外科醫生、心臟衰竭專家、監管事務專家和製造工程師進行的定性一手研究。技術評估包括對器械結構、血液相容性以及植入流程的檢驗。供應鏈評估檢驗了供應商多元化策略、製造地地點以及在近期貿易政策變化背景下的物流脆弱性。

針對臨床醫師、製造商和醫療系統決策者，總結磁浮心室輔助裝置技術策略意義的綜合結論

磁浮心室輔助裝置技術兼具工程創新與臨床應用前景，尤其在降低機械磨損和提高血液相容性方面，與傳統設計相比具有顯著優勢。要將技術優勢轉化為持續的臨床療效，需要在實證醫學證據收集、臨床醫生培訓和服務提供方面做出共同努力。同時投資於臨床註冊、外科培訓和供應鏈穩健性的醫療系統和器械開發商，將更有利於為晚期心臟衰竭患者帶來潛在益處。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章 美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

第8章磁浮心室輔助裝置市場（依流量類型分類）

  • 連續流
    • 軸流式
    • 離心流
  • 脈動流

第9章磁浮心室輔助裝置市場（依裝置類型分類）

  • 雙心室輔助裝置（BIVAD）
  • 左心室輔助裝置（LVAD）
  • 右心室輔助裝置（RVAD）

第10章 依治療應用分類的磁浮心室輔助裝置市場

  • 通往復健的橋樑
  • 移植橋樑
  • 目的地療法

第11章 依病患年齡層分類的磁浮心室輔助裝置市場

  • 成人
  • 兒童

第12章磁浮心室輔助裝置市場（依最終用戶分類）

  • 門診手術中心
  • 醫院

第13章磁浮心室輔助裝置市場（依通路分類）

  • 線上
  • 離線

第14章磁浮輔助裝置市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章磁浮心室輔助裝置市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國磁浮心室輔助裝置市場概況

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國磁浮心室輔助裝置市場

第17章：中國磁浮心室輔助裝置市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Berlin Heart GmbH
  • BiVACOR, Inc.
  • Calon Cardio-Technology Ltd.
  • CH Biomedical, Inc.
  • Cirtec Medical Corporation
  • Cleveland Heart, Inc.
  • Coridea, LLC
  • CorWave SA
  • Evaheart, Inc.
  • FineHeart SA
  • Leviticus Cardio Ltd.
  • Magenta Medical Ltd.
  • Medtronic plc
  • NuPulseCV, Inc.
  • ReinHeart TAH GmbH
  • Sun Medical Technology Research Corp.
  • Windmill Cardiovascular Systems, Inc.
Product Code: MRR-867BED9A9E98

The MagLev Ventricular Assist Device Market was valued at USD 715.28 million in 2025 and is projected to grow to USD 787.52 million in 2026, with a CAGR of 11.00%, reaching USD 1,485.75 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 715.28 million
Estimated Year [2026] USD 787.52 million
Forecast Year [2032] USD 1,485.75 million
CAGR (%) 11.00%

A focused introduction to maglev ventricular assist devices that frames clinical needs, engineering advances, and the convergence of patient care and device innovation

Maglev ventricular assist devices (VADs) represent an intersection of advanced magnetic levitation engineering and next-generation cardiovascular support, offering clinicians a pathway to reduced hemocompatibility complications and improved device longevity. Early adopters emphasize that the absence of mechanical bearings and the resulting lower shear stress can translate into gentler blood handling, and consequently fewer hemolytic and thrombotic events. These technical advantages have accelerated interest among multidisciplinary teams focused on durable circulatory support.

As a result, clinical programs are driven by an imperative to extend high-quality life for patients with advanced heart failure while reducing rehospitalization burdens. In parallel, engineering teams are optimizing control algorithms, miniaturized high-speed motors, and energy-efficient power delivery to reconcile the physiological demands of continuous support with practical constraints of implantation and patient mobility. Furthermore, regulatory pathways have started to adapt to device architectures that blend mechanical innovation with software-driven control, creating a dynamic environment for evidence generation and clinical validation.

The broader landscape is also shaped by hospital procurement priorities and payer scrutiny, which increasingly favor devices demonstrating robust safety profiles and measurable impacts on patient trajectories. Consequently, stakeholders from clinicians to commercial strategists are realigning investment and trial priorities to capture the promise of maglev-based circulatory support while addressing implementation challenges in varied care settings.

Transformative shifts reshaping the maglev ventricular assist device landscape driven by technology, clinical practice, and health policy realignment

Several concurrent shifts are redefining how clinicians, manufacturers, and health systems approach durable mechanical circulatory support. First, technological maturation in magnetic levitation platforms is enabling smaller, more efficient devices that can be programmed for tailored hemodynamic profiles. This evolution is prompting a re-evaluation of patient selection criteria, with clinicians exploring expanded indications when devices exhibit favorable safety and hemodynamic stability in early clinical use.

Second, clinical practice is gravitating toward multidisciplinary care pathways that integrate advanced heart failure specialists, perfusion teams, and outpatient management protocols. These coordinated approaches improve perioperative outcomes and reduce the friction associated with long-term device management. Third, regulatory agencies are placing greater emphasis on real-world evidence and post-market safety surveillance, which encourages manufacturers to design rigorous registries and investigator-initiated studies to demonstrate sustained benefit and device reliability.

Finally, supply chain resilience and manufacturing scale are becoming strategic differentiators as health systems prefer partners capable of consistent device availability and responsive service networks. Taken together, these shifts create a landscape where technological promise must be matched by clinical evidence, robust commercialization planning, and proactive stakeholder engagement to realize the full potential of maglev ventricular assist solutions.

Analysis of the cumulative impact of United States tariffs in 2025 on device components, supply chain resilience, and strategic sourcing decisions across the value chain

The tariff landscape introduced in 2025 has necessitated reassessment of component sourcing strategies for implantable maglev circulatory support systems. Key subsystems such as precision bearings, high-performance magnets, and power electronics are sensitive to supply chain cost inflation when tariff barriers affect sourced components. As a result, manufacturers and suppliers have accelerated vendor diversification, with emphasis on nearshoring and the qualification of alternate suppliers to mitigate disruption risk and preserve production cadence.

In addition to procurement strategies, engineering teams are prioritizing design-for-manufacturability initiatives that reduce reliance on tariff-exposed subassemblies by simplifying component counts and emphasizing modularity. Regulatory and quality groups have concurrently increased supplier audits and validated secondary sources to maintain device integrity while adapting to shifting trade conditions. Moreover, commercial teams are negotiating more flexible contracts and inventory buffers with customers and distributors to absorb lead-time variability without compromising clinical availability.

While tariffs have introduced immediate cost and logistics challenges, they have also catalyzed longer-term strategic changes. Stakeholders are investing in local manufacturing capabilities, enhancing supply chain transparency, and fostering partnerships with contract manufacturers capable of producing critical components within more stable jurisdictions. This systemic response aims to preserve patient access to advanced circulatory support while ensuring business continuity amidst geopolitical and trade-induced headwinds.

Key segmentation insights that illuminate distinct clinical, commercial, and operational pathways based on device architecture, therapy purpose, and user environment

Analysis by flow characteristics highlights meaningful differences in device selection and clinical application. Devices based on Continuous Flow architectures, which include Axial Flow and Centrifugal Flow subtypes, tend to prioritize prolonged circulatory support with compact implant configurations and continuous hemodynamic delivery. In contrast, Pulsatile Flow devices remain relevant for specific physiological profiles where rhythmic cardiac assistance may offer unique clinical benefits. These technological distinctions influence surgical approach, anticoagulation strategies, and patient monitoring protocols.

Device type segmentation clarifies use-case differentiation between Bivad, Lvad, and Rvad configurations, with biventricular systems reserved for patients with multi-chamber failure while left or right ventricular assist systems address isolated chamber dysfunction. Therapy application segmentation separates clinical intent into Bridge To Recovery, Bridge To Transplant, and Destination Therapy pathways, each carrying distinct evidence requirements and follow-up regimens that affect clinical trial design and payer engagement. End user segmentation distinguishes deployment contexts between Ambulatory Surgical Centers and Hospitals, where procedural capabilities, perioperative staffing, and post-discharge care will vary significantly.

Patient age group segmentation divides clinical approaches across Adult and Pediatric populations, driving differences in device sizing, growth considerations, and long-term management strategies for younger recipients. Finally, distribution channel segmentation between Direct Sales and Distributors shapes commercialization models and service-delivery expectations, with direct channels often enabling closer clinical collaboration and distributor channels facilitating broader geographic reach and inventory management. Together, these intersecting segmentation lenses reveal clear implications for product design, clinical protocols, reimbursement strategy, and commercial prioritization.

Regional insights that clarify demand drivers, clinical adoption patterns, and policy environments across major global territories for maglev circulatory support systems

In the Americas, advanced clinical infrastructure and concentrated centers of excellence support early adoption of novel circulatory support platforms, with academic hospitals often leading investigator-initiated evaluations and large health systems prioritizing integrated care pathways. These dynamics foster rigorous data collection and influence procurement decisions as payers and providers look for tangible improvements in patient outcomes and resource utilization. Transitioning from tertiary centers to broader hospital networks requires attention to training, service networks, and remote-monitoring capabilities.

The Europe, Middle East & Africa region demonstrates heterogeneous adoption driven by regional regulatory frameworks, variable reimbursement models, and differentiated hospital capabilities. In Western Europe, established cardiovascular programs and coordinated national health systems can expedite clinical rollouts and registry participation, while other jurisdictions in the region may face resource constraints that influence adoption timing. Policy emphasis on value-based care and national procurement programs often shapes commercial engagement and contracting approaches.

In the Asia-Pacific region, rapid investment in cardiovascular care capacity combined with a growing cohort of patients with advanced heart failure creates significant clinical interest. Regional manufacturing hubs and government initiatives to enhance domestic medical device capability also create favorable conditions for localized production and supply-chain collaboration. Across all regions, tailored clinician education, registry participation, and localized regulatory expertise are essential to translate device-level innovation into broad clinical impact.

Strategic company-level insights highlighting competitive positioning, innovation focus, and partnership structures shaping the maglev ventricular assist device arena

Leading device developers and specialized startups are differentiating through distinct combinations of clinical evidence generation, intellectual property around magnetic suspension and motor control, and manufacturing scale. Some players prioritize rapid clinical adoption by partnering with prominent cardiac centers to run investigator-led registries and early feasibility studies, while others concentrate on establishing resilient supply chains and scalable production capabilities that support broader commercial launches. Collaboration between engineering-focused firms and established cardiovascular device manufacturers accelerates time-to-clinic for complex subsystems while preserving regulatory rigor.

Investment patterns indicate that companies demonstrating an integrated pathway from bench to bedside-combining strong hemocompatibility data, ergonomically designed implant systems, and comprehensive post-implant support services-are more successful in securing strategic hospital partnerships. Furthermore, firms that develop modular platforms capable of supporting different therapy applications and patient anatomies have greater commercial flexibility. Across the competitive landscape, intellectual property strategies, quality system maturity, and the ability to demonstrate long-term reliability in real-world settings remain critical differentiators that influence partner selection and acquisition interest.

Actionable recommendations for industry leaders to align clinical evidence, manufacturing resilience, and commercial strategies for successful maglev device adoption

Focus on building robust clinical evidence pathways that combine prospective trials with comprehensive registries to capture both controlled outcomes and real-world performance metrics. Strengthening post-market surveillance and engaging key opinion leaders early in device development will accelerate clinical acceptance and provide the data necessary for payer discussions. Concurrently, invest in supplier qualification and regional manufacturing partnerships to reduce exposure to trade volatility and to maintain uninterrupted device availability for critical care settings.

Design devices with modularity and ease of implantation in mind to broaden the pool of implanting surgeons and to reduce procedural complexity. Align commercial models to the needs of hospitals and ambulatory surgical centers by offering training programs, remote monitoring services, and flexible service agreements that lower barriers to adoption. Finally, pursue strategic collaborations between engineering teams, clinicians, and regulatory experts to streamline submissions and to adapt evidence-generation plans to evolving regulatory expectations, thereby shortening the pathway from innovation to sustained clinical use.

Research methodology describing rigorous primary and secondary approaches, expert engagement, and cross-functional validation used to produce the analysis

This study synthesizes insights from a structured review of peer-reviewed clinical literature, regulatory filings, and device-specific technical documentation, paired with qualitative primary research through interviews with cardiac surgeons, heart failure specialists, regulatory affairs professionals, and manufacturing experts. Technical assessments included analysis of device architectures, hemocompatibility considerations, and implant procedural workflows. Supply chain evaluations examined supplier diversification strategies, manufacturing footprints, and logistics vulnerabilities in the context of recent trade policy shifts.

Cross-functional validation sessions were conducted with clinical advisors and industry experts to ensure that device performance characterizations and clinical pathway implications reflect practical realities. Regulatory pathway mapping incorporated recent guidance and post-market surveillance expectations to align evidence recommendations with contemporary requirements. Where appropriate, sensitivity analyses of supply chain scenarios were applied to evaluate operational resilience and strategic responses, and findings were integrated into actionable recommendations for commercial and clinical stakeholders.

Conclusion synthesizing the strategic implications of maglev ventricular assist technology for clinicians, manufacturers, and health system decision-makers

Maglev ventricular assist technology offers a compelling combination of engineering innovation and clinical promise, particularly in its potential to reduce mechanical wear and to improve hemocompatibility compared with legacy designs. Translating technological advantages into sustained clinical impact requires coordinated efforts in evidence generation, clinician education, and service delivery. Health systems and device developers that invest concurrently in clinical registries, surgical training, and supply chain robustness will be best positioned to realize the potential benefits for patients with advanced heart failure.

Moreover, evolving regulatory expectations and the changing trade environment necessitate proactive planning around post-market surveillance and strategic sourcing. Stakeholders who adopt a holistic approach-integrating engineering robustness, clinical validation, and commercial enablement-will accelerate adoption while managing risk. Ultimately, the successful rollout of maglev support systems depends not only on device performance but also on the ability of manufacturers and clinical partners to deliver consistent outcomes, scalable implantation pathways, and long-term patient support.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. MagLev Ventricular Assist Device Market, by Flow Type

  • 8.1. Continuous Flow
    • 8.1.1. Axial Flow
    • 8.1.2. Centrifugal Flow
  • 8.2. Pulsatile Flow

9. MagLev Ventricular Assist Device Market, by Device Type

  • 9.1. Bivad
  • 9.2. Lvad
  • 9.3. Rvad

10. MagLev Ventricular Assist Device Market, by Therapy Application

  • 10.1. Bridge To Recovery
  • 10.2. Bridge To Transplant
  • 10.3. Destination Therapy

11. MagLev Ventricular Assist Device Market, by Patient Age Group

  • 11.1. Adult
  • 11.2. Pediatric

12. MagLev Ventricular Assist Device Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals

13. MagLev Ventricular Assist Device Market, by Distribution Channel

  • 13.1. Online
  • 13.2. Offline

14. MagLev Ventricular Assist Device Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. MagLev Ventricular Assist Device Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. MagLev Ventricular Assist Device Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States MagLev Ventricular Assist Device Market

18. China MagLev Ventricular Assist Device Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Berlin Heart GmbH
  • 19.7. BiVACOR, Inc.
  • 19.8. Calon Cardio-Technology Ltd.
  • 19.9. CH Biomedical, Inc.
  • 19.10. Cirtec Medical Corporation
  • 19.11. Cleveland Heart, Inc.
  • 19.12. Coridea, LLC
  • 19.13. CorWave SA
  • 19.14. Evaheart, Inc.
  • 19.15. FineHeart SA
  • 19.16. Leviticus Cardio Ltd.
  • 19.17. Magenta Medical Ltd.
  • 19.18. Medtronic plc
  • 19.19. NuPulseCV, Inc.
  • 19.20. ReinHeart TAH GmbH
  • 19.21. Sun Medical Technology Research Corp.
  • 19.22. Windmill Cardiovascular Systems, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY THERAPY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AXIAL FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AXIAL FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AXIAL FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CENTRIFUGAL FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CENTRIFUGAL FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CENTRIFUGAL FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PULSATILE FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PULSATILE FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PULSATILE FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BIVAD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BIVAD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BIVAD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY LVAD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY LVAD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY LVAD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY RVAD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY RVAD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY RVAD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY THERAPY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY THERAPY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY THERAPY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY THERAPY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY THERAPY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY THERAPY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY THERAPY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY THERAPY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY THERAPY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY THERAPY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GCC MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. GCC MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 134. GCC MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. GCC MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY THERAPY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. GCC MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GCC MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. GCC MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY THERAPY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY THERAPY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. G7 MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. G7 MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. G7 MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 158. G7 MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. G7 MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY THERAPY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. G7 MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. G7 MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. G7 MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. NATO MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. NATO MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. NATO MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 166. NATO MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. NATO MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY THERAPY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. NATO MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. NATO MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. NATO MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY THERAPY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY FLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY THERAPY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA MAGLEV VENTRICULAR ASSIST DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)